Median CD4 cell count at the first diagnosis of each cancer type was 354 [IQR: 264–627] for patients with ICC, 718 [IQR: 408–943] for patients with BC and 402 [IQR: 271–630] for patients with CRC (Table 1). Here, CD4 is linked to colorectal carcinoma.